Atlas Trials

A Study of SYNT-101 to Test Safety, Tolerability and Pharmacodynamics of SYNT-101 in Healthy and Overweight Adults

Clinical trial NCT07307274 · RECRUITING

Trial details

NCT number
NCT07307274
Sponsor
Syntis Bio
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
HealthyOverweight and Obese Adults
Start date
2026-01-13
Primary completion
2026-10-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.